Stocks · Health care · Biological Products, (No Diagnostic Substances)

4D Molecular Therapeutics, Inc.

FDMT Clue Score62

United States Fiscal year ends December CIK 0001650648 Results filed 13 Aug 2026

Add to watchlist

What the insiders did Scheduled selling only

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$20.99K

$0.00 on a plan · $20.99K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$20.99K

$0.00 against sales at will